Troy A. Ignelzi - Chief Financial Officer at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

Troy A. Ignelzi - trading volume in the past year for Rapport Therapeutics, Inc.

Holdings reported by Troy A. Ignelzi for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,000 $99,800 $9.98 13 Mar 2025 Direct
Stock Option (Right to Buy) 142,000 03 Feb 2025 Direct Common Stock

Transactions reported by Troy A. Ignelzi for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.